U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 23 - 29, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 23 - 29, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Sara Brenner, M.D., M.P.H., Acting Commissioner for Food and Drugs

No Significant Event

Official Name: Kyle Diamantas, J.D., Acting Deputy Commissioner for Human Foods

Event Date: 03/24/2025
Location: College Park, MD
Subject: Poppy Seed Issues of Mutual Interest
FDA Participant/Group: MARK HARTMAN; STELLA SPYROPOULOS; TARYN WEBB; 
Non FDA Participant/Group: Philip Kahn-Pauli, Sarah Sorscher (Center for Science in the Public Interest); Betty Hacala, Steve Hacala (Private Citizen);

Official Name: Ritu Nalubola, Ph.D., Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 03/25/2025
Location: Washington, DC
Subject: Forum on Drug Discovery, Development, and Translation; Speaker: NIH Complement Animal Research in Experimentation (Complement-ARIE) Program; Achieving Representation in Clinical Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/25/2025
Location: Virtual
Subject: Institute for Gene Therapies Patient Advocacy Advisory Council Meeting; Q&A Session
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Institute for Gene Therapies Patient Advocacy Advisory Council

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 03/28/2025
Location: Virtual
Subject: 2025 Smokefree South Carolina: Tobacco Partners Roundtable; Speaker: FDA’s Comprehensive Approach to Addressing Youth Tobacco Product Use
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of the University of South Carolina Arnold School of Public Health and other registered guests

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top